Retractable Technologies, Inc. (RVP)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 82 | 188 | 95 | 44 | 33 | 38 | 34 | - |
| Operating profit | $m | -20 | -23 | ||||||
| Net profit | $m | 24 | 56 | 5 | -7 | -12 | -13 | -3 | - |
| EPS reported | $ | -0.43 | -0.12 | ||||||
| Operating cashflow per share | $ | -0.24 | -0.23 | ||||||
| Capex per share | $ | 0.02 | 0.02 | ||||||
| FCF per share | $ | -0.25 | -0.25 | ||||||
| Free cash flow | $m | -8 | -5 | ||||||
| Net debt | $m | -36 | -39 | ||||||
| Book value equity | $m | 74 | 73 | ||||||
| Book value per share | $ | 2.48 | 2.43 | ||||||
| Number of shares | m | 29.94 | 29.94 | ||||||
| DPS (TTM paid) | $ | 0.01 | 0.01 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 0.31 | 0.32 | ||||||
| P/S LTM | x | 0.60 | 0.68 | ||||||
| P/FCF LTM | x | -3.04 | -4.53 | ||||||
| EV/EBITDA LTM | x | -4.85 | 4.73 | ||||||
| EV/Sales LTM | x | 0.56 | 0.69 | ||||||
| Earnings Yield LTM | % | -54.36% | -16.26% | ||||||
| FCF Yield | % | -32.88% | -22.10% | ||||||
| Quality | |||||||||
| ROE | % | -16.89% | -4.59% | ||||||
| ROIC | % | -15.16% | -17.62% | ||||||
| Operating margin | % | -52.84% | -84.94% | ||||||
| Gross margin | % | +0.12% | +1.39% | ||||||
| FCF/Sales | % | -19.86% | -27.76% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | +15.78% | +2.58% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | +1.00% | 0.00% | ||||||
| Dividend Growth | % | -0.00% | -0.00% | ||||||
| Payout Ratio | % | -1.79% | -1.83% | ||||||
| FCF/Debt | x | -8.49 | -7.13 | ||||||
| Net Debt/EBITDA | x | 0.38 | 0.42 | ||||||
| EBIT/Net interest | x | -230.03 | -516.31 | ||||||
| Net debt/market cap | % | +3.87% | +1.83% | ||||||
| Net debt/Equity | x | -0.49 | -0.54 | ||||||
| Gross debt/equity | x | 0.01 | 0.01 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Retractable Technologies, Inc. is a medical device company focused on the innovation, production, and sale of secure medical instruments, predominantly syringes, for the healthcare sector. Their reach extends across the United States, the broader North and South American continents, and other international territories. The company's diverse product range includes a variety of safety-engineered items such as VanishPoint insulin, tuberculin, and allergy antigen syringes, as well as Patient Safe syringes and Luer Caps. They also offer small diameter tube adapters, blood collection tube holders, allergy trays, and IV safety catheters. Further offerings feature VanishPoint blood collection sets, EasyPoint needles, and VanishPoint autodisable syringes. Distribution of these products occurs through a combination of general and specialized distributors, international partners, and a dedicated direct sales network. Founded in 1994, the company's main operations are headquartered in Little Elm, Texas.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Retractable Technologies, Inc. (RVP)
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Retractable Technologies, Inc. is a medical device company focused on the innovation, production, and sale of secure medical instruments, predominantly syringes, for the healthcare sector. Their reach extends across the United States, the broader North and South American continents, and other international territories. The company's diverse product range includes a variety of safety-engineered items such as VanishPoint insulin, tuberculin, and allergy antigen syringes, as well as Patient Safe syringes and Luer Caps. They also offer small diameter tube adapters, blood collection tube holders, allergy trays, and IV safety catheters. Further offerings feature VanishPoint blood collection sets, EasyPoint needles, and VanishPoint autodisable syringes. Distribution of these products occurs through a combination of general and specialized distributors, international partners, and a dedicated direct sales network. Founded in 1994, the company's main operations are headquartered in Little Elm, Texas.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free